Angiotensin converting enzyme inhibitors. Properties and side effects.
- 1 March 1988
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 11 (3_pt_2) , II37-41
- https://doi.org/10.1161/01.hyp.11.3_pt_2.ii37
Abstract
The purpose of this brief review is to separate the characteristic properties and side effects attributable to the pharmacology of the whole class of angiotensin converting enzyme (ACE) inhibitors from those attributable to the chemical structure and kinetics of each particular ACE inhibitor. The former would be predictable and probably similar for all agents and, therefore, would be expected to recur with each agent, whereas the latter are likely to be characteristic of individual compounds and may be avoidable by changing to another compound with similar pharmacology but different molecular structure.Keywords
This publication has 66 references indexed in Scilit:
- Cough and Wheeze Caused by Inhibitors of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1986
- Reversible Panmyelopathie nach Captopril-MedikationDeutsche Medizinische Wochenschrift (1946), 1986
- Enalapril in Hypertension and Congestive Heart FailureDrugs, 1985
- EnalaprilDrugs, 1985
- Captopril-induced angioedemaAnnals of Emergency Medicine, 1984
- Captopril and Renal AutoregulationNew England Journal of Medicine, 1983
- Nekrotisierende Blepharitis nach Captopril-induzierter AgranulozytoseKlinische Monatsblätter für Augenheilkunde, 1983
- Leukopenia: Idiopathic or Drug-Induced?New England Journal of Medicine, 1982
- CaptoprilNew England Journal of Medicine, 1982
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978